‘Small Biotech Exception’ From Medicare Price Negotiation Granted To Four Drugs For 2026

 
• By Cathy Kelly

CMS has not disclosed how many requests for the exception it received but will follow up with applicants regarding its decisions this month.

lab research
CMS Criteria For Decisions On Applications Still To Come • Source: Shutterstock

More from Market Access

More from Pink Sheet